Authors who work with cameras need to know cons and pros of some of the most popular
Q ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium loremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. …
Q ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium loremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. …
1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC)
Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC
2. Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV)
Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, Managing Chemotherapy-Induced Nausea and Vomiting,…
THE US FDA APPROVALS
1. Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia
Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia
2. Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia
Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA
3. Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…
PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018
1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio
Published: 22 Jan, 2018 | Tags: Celgene, Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio
2. Sanofi to Acquire Bioverativ for its Hemophilia Products
Published: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat,…